<?xml version="1.0" encoding="UTF-8"?>
<ref id="bib0410">
 <label>21</label>
 <element-citation publication-type="journal" id="sbref0410">
  <person-group person-group-type="author">
   <name>
    <surname>Neal</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Perkovic</surname>
    <given-names>V.</given-names>
   </name>
   <name>
    <surname>Mahaffey</surname>
    <given-names>K.W.</given-names>
   </name>
   <name>
    <surname>de Zeeuw</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Fulcher</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Erondu</surname>
    <given-names>N.</given-names>
   </name>
   <collab>CANVAS Program Collaborative Group</collab>
  </person-group>
  <article-title>Canagliflozin and cardiovascular and renal events in type 2 diabetes</article-title>
  <source>N Engl J Med</source>
  <volume>377</volume>
  <year>2017</year>
  <fpage>644</fpage>
  <lpage>657</lpage>
  <pub-id pub-id-type="pmid">28605608</pub-id>
 </element-citation>
</ref>
